This protocol applies to patients with renal sarcoidosis who develop renal insufficiency as a consequence of sarcoidosis nephropathy — whether the underlying mechanism is interstitial nephritis or glomerular disease. Renal failure from either pathway is uncommon; when it occurs and does not respond to initial management, a defined escalation path exists.
The preceding line of management employed Prednisone with a gradual taper. The expected clinical goals — improvement in renal function and a meaningful decrease in serum creatinine — were not reached. Failure to meet those targets is the trigger for escalation to this protocol.
Sarcoidosis nephropathy manifests as interstitial nephritis more commonly than glomerular disease, although renal failure from either mechanism is uncommon.
While there is limited data upon which to base therapeutic recommendations, corticosteroids are usually used with evidence of renal insufficiency starting at 40 mg daily, with a slow wean of therapy as used for other organ involvement.
Rarely renal transplantation is needed.
View source ↗